Supplementary Scheme Booklet

• Updated timetable for the Scheme
• Update on sale and leaseback of facility in South-West Western Australia
• Board continues to unanimously recommend shareholders vote in favour of the Scheme

Little Green Pharma Ltd (ASX: LGP) has released a Supplementary Scheme Booklet in relation to its proposed acquisition of 100% of the issued capital of Cannatrek Ltd by way of a scheme of arrangement. The Supplementary Scheme Booklet provides additional information regarding the updated timetable for the Scheme and an update from LGP on the sale and leaseback of the facility in South-West Western Australia. The Board of Cannatrek continues to unanimously recommend that Cannatrek Shareholders vote in favour of the Scheme, in the absence of a Superior Proposal and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of Cannatrek Shareholders. Each member of the Cannatrek Board intends to vote in favour of the Scheme for all Cannatrek Shares held or controlled by them, which is expected to be approximately 22.35% of Cannatrek Shares as at the date of the Scheme Meeting. The Independent Expert has concluded that the Scheme is fair and reasonable and that the Scheme is in the best interests of Cannatrek Shareholders, in the absence of a Superior Proposal.